| Name | Title | Contact Details |
|---|
Jenson Medical International is a Conroe, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Perimed is a North Royalton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pediatric Services of America, Inc (PSA Healthcare) is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Pediatric Services of America, Inc (PSA Healthcare) is based in Norcross, GA. You can find more information on Pediatric Services of America, Inc (PSA Healthcare) at www.psahealthcare.com
At Lane Regional Medical Center, we value community and take pride in the role we play as caregivers. It is an honor to say that we serve as the primary healthcare resource for more than 200,000 of our neighbors located throughout Zachary and the surrounding region of Baker, Central, Clinton, Jackson, St. Francisville, New Roads, North Baton Rouge and Southern Mississippi. As part of our continued dedication to serving our community and providing the highest quality of care, we continue to recruit new physicians to the area and to provide access to the very best healthcare services, technologies and programs available in the region.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.